Literature DB >> 22052336

Outcomes following surgery without radiotherapy for rectal cancer.

K L Mathis1, D W Larson, E J Dozois, R R Cima, M Huebner, M G Haddock, B G Wolff, H Nelson, J H Pemberton.   

Abstract

BACKGROUND: This study determined survival and recurrence rates following curative resection of rectal cancer without radiotherapy.
METHODS: This was a retrospective review of the Mayo Clinic database of patients with rectal cancer treated with curative intent using surgery alone from 1990 to 2006. Patients who received neoadjuvant chemotherapy or radiation therapy and those who had any postoperative radiotherapy were excluded. Details were collected from the database and patient records using a protocol approved by the institutional review board.
RESULTS: Some 655 consecutive patients with rectal cancer treated with curative intent using surgery alone were identified; 397 had stage I disease, 125 stage II and 133 stage III. Four hundred and nine patients underwent anterior resection (AR) and 246 abdominoperineal resection (APR). Median follow-up was 62 months. The 5-year rate of local recurrence was 4·3 per cent, disease-free survival 90·0 per cent and cancer-specific survival 91·5 per cent. Stage-specific and all-stage disease-free survival did not differ significantly between AR and APR. The 5-year cumulative local recurrence rate was lower following AR than APR (3·6 versus 5·5 per cent; P = 0·321). There were only two patients with positive margins and type of operation was not significant on multivariable analysis.
CONCLUSION: Well-performed, standardized APRs have similar local recurrence to AR. Radiation therapy may not confer much additional benefit.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22052336     DOI: 10.1002/bjs.7739

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  15 in total

Review 1.  Abdominoperineal Excision: Technical Challenges in Optimal Surgical and Oncological Outcomes after Abdominoperineal Excision for Rectal Cancer.

Authors:  Torbjörn Holm
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

2.  Are we denying distant control? A call for revising the treatment protocols of patients with ultra-low rectal cancer who potentially require abdominoperineal resection.

Authors:  Bilal Baker; Abdel-Munem Abu Sba
Journal:  J Gastrointest Cancer       Date:  2014-06

3.  Analysis of outcomes of intra-operative rectal washout in patients with rectal cancer during anterior resection.

Authors:  Zhang Xingmao; Bi Jianjun; Wang Zheng; Liang Jianwei; Hu Junjie; Zhou Zhixiang
Journal:  Med Oncol       Date:  2013-01-04       Impact factor: 3.064

4.  No observable difference in operative oncological outcomes between extra-levator versus standard abdominoperineal excision.

Authors:  K J Gash; L Cooper; N Smart; R Longman; M Thomas
Journal:  Tech Coloproctol       Date:  2014-05-07       Impact factor: 3.781

5.  Clinically Node Negative, Pathologically Node Positive Rectal Cancer Patients Who Did Not Receive Neoadjuvant Therapy.

Authors:  Nouf Akeel; Nan Lan; Luca Stocchi; Meagan M Costedio; David W Dietz; Emre Gorgun; Matthew F Kalady; Georgios Karagkounis; Hermann Kessler; Feza H Remzi
Journal:  J Gastrointest Surg       Date:  2016-10-27       Impact factor: 3.452

Review 6.  Paradigm-shifting new evidence for treatment of rectal cancer.

Authors:  Alessandro Fichera; Marco E Allaix
Journal:  J Gastrointest Surg       Date:  2013-07-26       Impact factor: 3.452

7.  Extralevator versus standard abdominoperineal excision for rectal cancer.

Authors:  S K Perdawood; T Lund
Journal:  Tech Coloproctol       Date:  2014-11-11       Impact factor: 3.781

8.  Correlation of rectal tumor volumes with oncological outcomes for low rectal cancers: does tumor size matter?

Authors:  Muhammad Tayyab; Abdul Razack; Abhiram Sharma; James Gunn; John E Hartley
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

Review 9.  Controversies in the multimodality management of locally advanced rectal cancer.

Authors:  Robert Díaz Beveridge; Dilara Akhoundova; Gema Bruixola; Jorge Aparicio
Journal:  Med Oncol       Date:  2017-04-24       Impact factor: 3.064

10.  Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis?

Authors:  Bin Jiang; Jeffrey Mason; Anahid Jewett; Jun Qian; Yijiang Ding; William C S Cho; Xichen Zhang; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2013-01-11       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.